News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nextcure Inc
(NQ:
NXTC
)
1.290
-0.030 (-2.27%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nextcure Inc
< Previous
1
2
3
Next >
NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results
November 07, 2024
From
NextCure
Via
GlobeNewswire
NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting
November 05, 2024
From
NextCure
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
October 28, 2024
Via
Benzinga
NXTC Stock Earnings: NextCure Beats EPS for Q4 2023
March 21, 2024
NXTC stock results show that NextCure beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
October 04, 2024
From
NextCure
Via
GlobeNewswire
NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024
September 16, 2024
From
NextCure
Via
GlobeNewswire
NXTC Stock Earnings: NextCure Misses EPS for Q2 2024
August 01, 2024
NXTC stock results show that NextCure missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results
August 01, 2024
From
NextCure
Via
GlobeNewswire
NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
June 20, 2024
From
NextCure
Via
GlobeNewswire
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
May 30, 2024
From
NextCure
Via
GlobeNewswire
NXTC Stock Earnings: NextCure Misses EPS for Q1 2024
May 02, 2024
NXTC stock results show that NextCure missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
May 02, 2024
From
NextCure
Via
GlobeNewswire
NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
April 24, 2024
From
NextCure
Via
GlobeNewswire
NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
April 08, 2024
Poster presentation highlights strong safety and pharmacokinetic profiles for LNCB74
From
NextCure
Via
GlobeNewswire
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
April 04, 2024
From
NextCure
Via
GlobeNewswire
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
NextCure
Via
GlobeNewswire
Wall Street’s Favorite Penny Stocks? 7 Names That Could Make You Filthy Rich
March 23, 2024
The market is surging higher after dovish Fed comments. Here are seven of Wall Street’s favorite penny stocks that can help make you rich
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
12 Health Care Stocks Moving In Friday's After-Market Session
March 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 21, 2024
Via
Benzinga
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
March 21, 2024
From
NextCure
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 06, 2024
Via
Benzinga
NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
March 05, 2024
From
NextCure
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
February 16, 2024
Via
Benzinga
NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders
January 18, 2024
From
NextCure
Via
GlobeNewswire
NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury
December 21, 2023
From
NextCure
Via
GlobeNewswire
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 14, 2023
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 14, 2023
Via
Benzinga
US Stocks Higher; Initial Jobless Claims Fall To 202,000
December 14, 2023
U.S. stocks traded higher this morning, following the release of economic reports on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 37,180.82 while the NASDAQ rose 0.60% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 14, 2023
Via
Benzinga
NextCure Provides Year-End Clinical Pipeline Updates
December 14, 2023
From
NextCure
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.